Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares - Centessa Pharmaceuticals ( NASDAQ:CNTA )
BOSTON and LONDON, Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- Centessa Pharmaceuticals plc CNTA, a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced the pricing of an upsized underwritten public offering of ...
| Ticker |
Sentiment |
Impact |
|
EVR
|
Neutral
|
11 %
|
|
STT
|
Neutral
|
5 %
|
|
GS
|
Neutral
|
11 %
|
|
CNTA
|
Neutral
|
21 %
|
